Notify me when JOSEPH EDELMAN files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | Common Stock, $0.0001 par value | 20.1% | $8.07M | $5.7M | 1.87M | +240% | Joseph Edelman | 23 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|